Zobrazeno 1 - 6
of 6
pro vyhledávání: '"B. Y. Yeap"'
Publikováno v:
Neurochirurgie Scan. :264-265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed51e678b9afbcc36b4bb2e338c260e3
https://doi.org/10.1055/s-0042-111737
https://doi.org/10.1055/s-0042-111737
Autor:
Lesley A. Stewart, S. B. Kaye, S. Pecorelli, N. Colombo, C. Mangioni, R. V. Smalley, B. Y. Yeap, D. W. Wilbur, R. C. Leonard, M. F. Brady, E. Wiltshaw, P. F. Conte, S. Marsoni, J. F.G. Sturgeon, M. H.N. Tattersall, C. Gennatas, C. Trope, A. Athanazziou, D. Guthrie, D. Crowther, D. R. Bell, A. H. Laing, M. Gore, J. B. Vermorken, C. Lewis, E. Gilbey, Giorgio Bolis, H. Bruckner, P. Adnitt, M. K.B. Parmar, M. Tomirotti, H. Meerpohl, H. S. Brodovsky, W. Sauerbrei, J. Pater, R. Canetta, W.W. ten Bokkel Huinink, D. V. Skarlos, H. J. Solomon, M. J. Webb, J. T. Wharton, F. Landoni, P. Y. Liu, M. M. Turbow, J. H. Edmonson, D. S. Alberts, C. J. Cohen, K. Aabo, W. Torri, V. Barley, M. Adams, M. Buyse, C. J. Williams, M. Presti, V. Chylak, U. Bianchi, G. A. Omura
Publikováno v:
Scopus-Elsevier
The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent vs combination and carboplatin vs cisplatin) in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2151ac8be4c1ee28ab74e9cc655baa87
https://doi.org/10.1038/bjc.1998.710
https://doi.org/10.1038/bjc.1998.710
Publikováno v:
Cancer. 72(8)
Recent clinical trials have documented activity for combinations of chemotherapeutic agents that target the microtubular apparatus in patients with hormone-refractory prostate cancer. Taxol has a novel antimicrotubular mechanism, acting by stabilizin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94f57a71a1c13ad5660d03a344a50936
https://pubmed.ncbi.nlm.nih.gov/8104680
https://pubmed.ncbi.nlm.nih.gov/8104680
Publikováno v:
Cancer. 68(4)
Pulmonary toxicity may complicate the treatment of non-Hodgkin's lymphoma (NHL). The possible drug-related cause of pulmonary toxicity was investigated retrospectively in 207 NHL patients treated between 1981 and 1988 with three regimens containing c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8e34a8c4c2591877c225a6773ccbdaf7
https://pubmed.ncbi.nlm.nih.gov/1713121
https://pubmed.ncbi.nlm.nih.gov/1713121
Autor:
J D, Licht, L D, Bosserman, J W, Andersen, B Y, Yeap, M M, Klatt, J K, Martel, K C, Anderson, D S, Rosenthal, G, Pinkus, A T, Skarin
Publikováno v:
Cancer. 66(4)
To define the role of intensive combination chemotherapy in the treatment of low-grade or intermediate-grade lymphomas, the authors report results in 49 patients treated with intermediate-dose or high-dose methotrexate, bleomycin, Adriamycin (doxorub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5af7e68a0d02debe47ccea93a79aea95
https://pubmed.ncbi.nlm.nih.gov/1696844
https://pubmed.ncbi.nlm.nih.gov/1696844
Autor:
G P, Canellos, A T, Skarin, M M, Klatt, D S, Rosenthal, D C, Case, G S, Pinkus, M S, Jochelson, B Y, Yeap, M A, Shipp
Publikováno v:
Seminars in hematology. 24(2 Suppl 1)
The m-BACOD regimen attempted to lower the dose of methotrexate in the M-BACOD (methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone) program. Between July 1981 and January 1985, 87 previously untreated or minimally trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4dc882c99bad0d3728c270c646db421
https://pubmed.ncbi.nlm.nih.gov/2438777
https://pubmed.ncbi.nlm.nih.gov/2438777